Last updated on September 2017

An open-label phase IIIb study of regorafenib in patients with metastatic colorectal cancer (CRC) who have progressed after standard therapy


Other Details:

For Study Locations, Click Here



Find a site near you

Start Over

Research Center

Located In: Additional Locations, MN USA
  Connect »